AMA Pushes for Widespread Telehealth Adoption
WEDNESDAY, Dec. 2, 2020 -- At a Special Meeting of the AMA House of Delegates, the American Medical Association (AMA) adopted a new policy to advocate for widespread adoption of telehealth beyond the COVID-19 pandemic.
According to the resolution, the AMA will advocate for the federal government and the Centers for Medicare & Medicaid Services, state governments and agencies, and the private health insurance industry to implement uniform rules and regulations for adoption of telehealth technology. Additionally, the AMA is pushing for increased funding and planning for telehealth infrastructure such as broadband and internet-connected devices for both physician practices and patients to support equitable access to telehealth services.
The AMA cited a recent survey by the COVID-19 Healthcare Coalition as evidence of support for telehealth. The survey revealed that 60 percent of responding physicians said that telehealth improved the health of their patients, and more than two-thirds (68 percent) reported they are motivated to increase telehealth use in their practices. Yet, nearly three-quarters of respondents (73 percent) said that reimbursement would be a challenge post-COVID-19 and that technology poses a barrier for sustained use of telehealth.
© 2021 HealthDay. All rights reserved.
Posted: December 2020
Read this next
THURSDAY, Jan. 21, 2021 -- Tocilizumab plus standard care is not superior to standard care alone for improving clinical outcomes among patients with severe or critical COVID-19...
THURSDAY, Jan. 21, 2021 -- For adults with COVID-19-related critical illness admitted to the intensive care unit (ICU), mortality has decreased over time, according to a study...
THURSDAY, Jan. 21, 2021 -- A day after his inauguration, President Joe Biden plans to unveil a new, far-reaching pandemic response plan. He will also issue executive orders that...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.